At Nasdaq opening bell, Anthropic CEO recommits to pacing AI development
Reported by Business Insider and TechCrunch2 sources ↓
Latest in this story: Anthropic shares fall after their blockbuster first day of trading
At Anthropic’s Nasdaq debut, CEO Dario Amodei said the company would pace AI training and deployment until it had confidence its systems were safe and would remain under human control.
Key points
- Amodei said Anthropic would continue work on AI alignment, testing and understanding AI behavior
- He cited misuse by individuals or nations, economic disruption and loss of control as AI risks
- Amodei said AI could help speed medical research, but called the results so far early
Sources
Details
In his opening-bell speech, Amodei said Anthropic would not yield to business or political pressure on safety. He described safeguards as necessary to address the risks of AI, including misuse by individuals or nation-states, economic disruption and losing control of AI systems.
Amodei said Anthropic would continue developing alignment and testing methods and ways to understand AI behavior. He also said the company’s AI tools were helping researchers in fields such as protein folding, drug design and cancer genetics, while stressing that experiments and clinical trials still take time.
TechCrunch reports that other technology leaders had expressed agreement with his position, but few concrete commitments had followed.
Written from coverage as of
How this story developed
- Anthropic files for an IPO, disclosing its finances and governance structure
- Investors question whether Anthropic can achieve a $1.5 trillion IPO valuation
- Anthropic launches its IPO roadshow with a $70-to-$78 share price range
- Anthropic seeks a valuation of about $1.3 trillion in its IPO
- Anthropic prices its IPO at $83 a share, above the marketed range
Images
- TechCrunch
Stocks in this story
Change since open: 20 Nov to 21 Nov 2026
Last refresh